Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradiscal Corticoids in Modic I Discopathies
NCT01694134Phase 3Completed
- Sponsor
- CHU Montpellier
- Start
- Jul 2012
- Primary completion
- Mar 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of prednisolone in intervertebral disc degeneration (DDD) (2 arms), sponsored by CHU Montpellier. Primary endpoint: Visual Analog Scale for Pain at 1 month. Started Jul 2012; status: completed.
02
Drugs
prednisolone
03
Conditions
intervertebral disc degeneration (DDD)
Beyond the preview
Go deeper on NCT01694134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01694134.